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Salmonella Typhimurium (S. Typhimurium) is responsible for foodborne zoonotic
infections that, in humans, induce self-limiting gastroenteritis. The aim of this study
was to evaluate whether the wild-type strain S. Typhimurium (STM14028) is able to
exploit inflammation fostering an active infection. Due to the similarity between human
and porcine diseases induced by S. Typhimurium, we used piglets as a model for
salmonellosis and gastrointestinal research. This study showed that STM14028 is able to
efficiently colonize in vitro porcine mono-macrophages and intestinal columnar epithelial
(IPEC-J2) cells, and that the colonization significantly increases with LPS pre-treatment.
This increase was then reversed by inhibiting the LPS stimulation through LPS antagonist,
confirming an active role of LPS stimulation in STM14028-intracellular colonization.
Moreover, LPS in vivo treatment increased cytokines blood level and body temperature
at 4 h post infection, which is consistent with an acute inflammatory stimulus, capable
to influence the colonization of STM14028 in different organs and tissues. The present
study proves for the first time that in acute enteric salmonellosis, S. Typhimurium exploits
inflammation for its benefit in piglets.
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Introduction
Salmonella enterica serovar Typhimurium (S. Typhimurium) is a pathogenic Gram-negative
bacterium of great clinical significance, responsible for foodborne zoonotic infections. The human
disease is characterized by self-limiting gastroenteritis that occasionally can cause fever, systemic
infection, and severe inflammation of the intestinal mucosal epithelium (Haagsma et al., 2008; Pires
et al., 2011).
The architecture of the mucosal epithelium contains several barriers that prevent or block
infection by pathogenic bacteria. Mechanisms of protection are exerted by all of these barriers in
order to maintain the integrity of the epithelial cell monolayer and limit inflammation-associated
damage (Patel andMcCormick, 2014). S. Typhimurium, however, is able to overcome these barriers
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and therefore to colonize the intestinal epithelium inducing
inflammation and a marked host immune response. The
inflammatory response in the gut is induced by the interaction
of S. Typhimurium with host cells including epithelial cells and
antigen-presenting cells (APCs), like macrophages and dendritic
cells. The inflammation is characterized by the secretion of
several cytokines, including interleukin (IL)-23 and IL-18, which
in turn stimulates T cells to produce IL-17, and IL-22 in the
gut mucosa (Srinivasan et al., 2007; Godinez et al., 2008, 2009;
Raffatellu et al., 2008).
S. Typhimurium acquired an evolutionary adaptation to
overcome antimicrobial defenses in the lumen of the inflamed
intestine and, more importantly, to exploit inflammation
in order to outcompete the intestinal microbiota (Lupp
et al., 2007; Stecher et al., 2007; Barman et al., 2008;
Lawley et al., 2008; Sassone-Corsi and Raffatellu, 2015). The
capability of S. Typhimurium to grow in the inflamed mucosal
environment relies upon the acquisition of essential nutrients and
anaerobically respired tetrathionate to successfully outgrow the
resident microbiota (Raffatellu et al., 2009; Winter et al., 2010;
Liu et al., 2012; Behnsen et al., 2015).
Most of the current studies about S. Typhimurium infection
have been conducted in mice, which naturally do not develop
gastroenteritis, but rather a systemic infection. An experimental
mouse model using antibiotic treatment in order to eliminate
microflora and to induce colitis, has been recently established
(Ahmer and Gunn, 2011). However, this model is based on
the lack of an intact microbiota, which limits a comprehensive
evaluation of the complex interactions of S. Typhimurium within
the gastrointestinal environment (Elfenbein et al., 2013). Here,
we utilized pigs as model for gastrointestinal research with the
aim of evaluating whether S. Typhimurium is able to exploit
inflammation favoring an active infection. Our findings provide
evidence that the LPS administration induces inflammation that
favors a significant increase in colonization of tonsils, cecum, and
spleen by S. Typhimurium.
Materials and Methods
Salmonella spp. Cultures
A wild-type strain of Salmonella Typhimurium ATCC 14028
(STM14028) was used throughout the study. The strain was
grown overnight at 37◦C in Brain Heart Infusion broth (Oxoid
Ltd, UK), harvested by centrifugation at 1500× g for 10min and
then washed twice in ice-cold (+4◦C) phosphate buffer solution
(PBS) (Sigma-Aldrich, Italy).
In vitro STM14028 Colonization
Porcine peripheral blood mononuclear cells (PBMCs) were
isolated from whole blood by Ficoll centrifugation and
resuspended in complete RPMI-1640 medium (Sigma-Aldrich,
St. Louis, MO) supplemented with 10% fetal bovine serum (FBS,
Gibco-BRL, USA), 2mM L-glutamine, Gentamicin (100µg/ml).
Mono-macrophage cells were isolated from porcine PBMCs, by a
4 h plastic adherence procedure at 37◦C in 5% CO2 atmosphere,
followed by extensive washing with PBS (2 times per day for the
first 5 days) to eliminate the lymphocyte contamination. After
7–10 days mono-macrophage cells were obtained, the purity of
which was ≥90% as determined by FACS (anti-CD14 Mil-2mAb
AbCAM cat. 23919-1, and anti-pig macrophages mAb, AbD
Serotec, cat MCA2317F). Cells were then collected, resuspended
in complete medium, and transferred into 200µL per wells
of 96-well round-bottom microtiter plates. The IPEC-J2 cell
line, porcine intestinal columnar epithelial cells established from
normal jejunum of a neonatal unsuckled pig (ACC 701), were
grown in Minimum Essential Medium (MEM) (Sigma-Aldrich,
St. Louis, MO) enriched with Fetal Calf Serum (FCS, Gibco-BRL,
USA) (10% v/v), 2mM glutamine, and antibiotics (50µg/mL
penicillin, 50µg/mL streptomycin, and 10µg/mL neomycin), at
37◦C in 5% CO2 atmosphere. Mono-macrophages and IPEC-
J2 cell line were employed for in vitro studies. Both types of
cells were seeded in 96-well plates at a density of 1 × 105 cells
per well and treated overnight with purified lipopolysaccharides
(LPS) (1µM/mL; from Escherichia coli 0111:B4, L4391; Sigma-
Aldrich) alone or in combination with a natural antagonist of
LPS, the RS-LPS (100µM/mL; tlrl-prslps, Invivogen, San Diego,
USA). The following day, cell cultures were rinsed and STM14028
was diluted in RPMI-10% FBS, added to the cells at a multiplicity
of infection (MOI) of 100:1 and incubated for 1 h at 37◦C in 5%
CO2. After 1 h, the cell cultures were rinsed and incubated in a
culture medium containing gentamicin sulfate (100µg/ml) to kill
extracellular bacteria but not the internal ones, and subsequently
incubated for 3 and 24 h. Viable intracellular bacteria were
recovered by lysing the cells, at both 3 and 24 h post treatment
time point, in distilled water with 0.1% of Triton X-100 for
10min. The quantification of bacteria was performed by plating
serial dilutions on agar triptose plates.
In vivo Studies
Animals
Fourteen commercial hybrid pigs aged ∼30 days were utilized
in the experiment. All the pigs used throughout the study were
the offspring of Salmonella-free sows (negative for Salmonella
by both serological and bacteriological tests). Before the onset
of the experiment, the piglets were proved to be Salmonella-
free by culture of feces of each animal. Animals were weighed
and randomly allocated to two groups of 6 (A and B) and one
group (C) of two pigs. Each group was maintained in separate
isolation units under natural day–night rhythm with access to
feed and water ad libitum. Groups A and B were intragastrically
administered with 20ml of sodium bicarbonate buffer containing
109 CFU of S. Typhimurium ATCC 14028. At the same time,
Group A was intraperitoneally challenged with 12.5µg/kg BW
of lipopolysaccharides from S. enterica serovar Typhimurium
(L2262, Sigma Aldrich SRL, Milan, Italy). Group C received only
sterile sodium bicarbonate buffer and served as naïve control
group. Collection of individual fecal samples (0, 1 day after
challenge), blood sampling and registration of rectal temperature
(0, 4 h, 1 and 2 days after challenge) were performed as well. Pigs
were visually monitored by an independent veterinary officer in
charge of the study for 6 h after the inoculum and then twice a
day. Two days after the challenge, pigs were weighed again, and
then euthanized using a captive bolt pistol and exsanguination.
Samples of tonsils, liver, spleen, mesenteric lymph nodes, ileum,
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cecum, and colon were collected from each pig for the evaluation
of bacterial burden.
All the experiments were authorized by national authority
and were conducted according to the Italian national regulations
enforced at the time of this study (Italian legislative Decree
116/92).
Microbiology
The microbiological analysis of fecal and organ samples were
conducted according to the ISO 6579:2002/Amendment 1:2007
protocol. Briefly, samples were weighed and homogenized as 10%
suspension in Buffered Peptone Water (BPW) (Oxoid Ltd., UK).
This initial solution was then used to perform a decimal dilution
series carried out by systematically transferring an aliquot of 1ml
of each successive dilution in 9ml of BPW. All BPW-diluted
samples were incubated at 37◦C for 18 ± 3 h. Cultures (0.1ml)
were subsequently seeded on Modified Semisolid Rappaport-
Vassiliadis (MSRV) agar plates (Oxoid Ltd., UK) and incubated
at 41.5◦C for 24 h for the selective enrichment of Salmonella.
A loopful of growth from each MSRV plate was streaked
onto Xylose-Lysine-Desoxycholate Agar (Oxoid Ltd., UK) and
Brilliant GreenAgar (Oxoid Ltd., UK) plates and hence incubated
at 37◦C overnight. Typical colonies were confirmed serologically
as Salmonella by polyvalent antiserum (Salmonella Test Serum;
Siemens Healthcare Diagnostics, Italy) and API rapid 20 E
(Api Rapid 20E; Biomerieux, Italy). This is a semi-quantitative
approach that allow the determination of the concentration of
Salmonella in a sample within a tenfold band.
Flow Cytometry of Lymph Nodes Cells
Cell treatment was performed according to an established
procedure (Razzuoli et al., 2012), with minor modifications.
Briefly, frozen lymph nodes cells were thawed at 38◦C and
washed with FACS-Buffer (0.1% sodium azide + 2% fetal calf
serum in PBS). Then, they were divided into aliquots (106
cells each) and reacted with monoclonal antibody (mAb) CD21
(Southern Biotech, cat. 4530-02), Mil-2 (AbCAM, cat. 23919-
1), PMN (AbD Serotec, cat. MCA2599F), or FACS buffer only
(control) for 30min at 4◦C, respectively. Cells were washed, and
again incubated for 30min at 4◦C in FACS buffer containing
goat anti-mouse IgG-FITC (Invitrogen, Molecular Probes R©, cat:
A10683). After washing in FACS buffer, cells were resuspended in
100µL of the same buffer and 1:4 diluted. Samples were analyzed
in a GUAVA MILLIPORE flow cytometer (Millipore Software).
The typical forward and side scatter gate was set to exclude dead
cells from the analysis. The percentage of positive cells beyond the
threshold fluorescence channel was assessed in each sample on
10,000 events and compared between mAb-treated and control
cells. For each antibody, results were expressed in terms of net
percentage of positive cells.
Analysis of Cytokines
In order to evaluate the serum concentration of IL-1 beta
and TNF-alpha ELISA kits were used (cat. N. PLB00B and
PTA00 respectively, R&D Systems, Inc. Minneapolis, MN 55413,
USA,). These assays employ the quantitative sandwich enzyme
immunoassay technique using monoclonal antibodies, specific
for porcine IL-1 beta or porcine TNF- alpha, pre-coated onto a
microplate. The intensity of the color measured is at 450 nm.
Statistical Analysis
For the in vitro and in vivo assays, the statistical significance of
differences between study groups was analyzed using ANOVA
and Student’s t-test; p < 0.05 was chosen as threshold for
significance. These symbols were used to indicate the statistical
significance: ∗P < 0.1; ∗∗P < 0.01; ∗∗∗P < 0.001; ∗∗∗∗P <
0.0001.
Results
Salmonella Infection Induces an Innate Immune
Response
In order to verify the involvement of the innate immune
response during Salmonella infection in piglets, phenotypic
analysis in ileo-cecal lymph nodes was performed in piglets
orally infected with STM14028 and euthanized 48 h later. As
depicted in Figure 1A, it was possible to observe a higher
increase in the percentage of CD14+ (mainly monocytes) and
polymorphonuclear cells with a minor involvement of CD21+
B cells. Moreover, the STM14028-infection was confirmed by
FIGURE 1 | STM14028 infection induces an increase of innate immunity
cell compartment and colonizes different organs of piglets orally
infected. (A) The prevalence of CD14+, CD21+, and polymorphonuclear
(PMN) cells was determined in ileo-cecal lymph nodes, 48 h post-infection with
STM14028. The differences were statistically significant (***P ≤ 0.001, multiple
comparisons t-test). (B) STM14028 count in ileo-cecal lymph nodes (ICLN),
spleen, colon, and cecum of infected piglets. Data represent mean with error
bars as SEM of six piglets per group.
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the bacterial count in different organs (Figure 1B). These
findings are consistent with a rapid recruitment of neutrophils
and monocytes/macrophages toward lymph nodes, crucial
for the effective response to lipopolysaccharides stimulus or
concomitant bacterial infection. These data suggest a prompt
involvement of the innate immune response in the regional
lymph nodes draining the gut, after an oral infection with
STM14028.
LPS Treatment Increases STM14028 Colonization
in Isolated Mono-macrophages and IPEC-J2
Cells
In order to assess if STM14028 exploits inflammation in vitro,
we used LPS, which is known to stimulate the production
of inflammatory molecules either in monocytes/macrophages
(Fang et al., 2004) or in IPEC-J2 cells (Razzuoli et al., 2013).
Monocytes/macrophages and IPEC-J2 cells were thus primed
overnight with purified LPS alone and/or in combination with
a natural antagonist of LPS (RS-LPS) capable to inhibit the
LPS-stimulation interacting with the TLR-4/MD-2 complex
recognized by LPS. Afterwards, the cells were infected with
STM14028.
We observed that STM14028 was able to efficiently colonize
monocytes/macrophages and IPEC-J2 cells at both 3 and 24 h
post STM14028-infection (Figures 2A–D). A previous treatment
with purified LPS significantly increased STM14028 colonization
in both cell types at 3 and 24 h after infection. When RS-LPS
antagonist was used, this markedly inhibited LPS stimulation
causing a colonization level similar to the one obtained by
STM14028 infection alone (Figures 2A–D). Overall, these results
suggest that LPS stimulation can create conditions in which
STM14028 is more efficiently phagocytized by cultivated cells,
within it can find suitable conditions to multiply.
LPS Induces Inflammation in Piglets, Which in
Turn Favors STM14028 Colonization
To evaluate the influence of inflammation during Salmonella
infection in vivo, we established a protocol of inflammation,
injecting parenterally LPS in group A and STM14028 by oral
route in groups A and B. Piglets in group C were kept untreated
and served as control animals. Then, an assessment was made
of whether inflammation induced by LPS had favored the
progression of Salmonella infection.
LPS was able to induce a rise in body temperature in piglets
of group A already at 4 h post STM14028-infection (Figure 3)
compared to the control (C) and the STM14028-infected group
(B), reaching body temperature similar to those of group A only
at 24 and 48 h post infection. No significant differences in body
weight were measured among the three groups throughout the
48 h of analysis (data not shown).
Moreover, a remarkable increase of circulating pro-
inflammatory cytokines has been found (Figure 4). TNF-alpha
was in fact detected in the blood of all animals but it was
produced in a higher amount in group A compared to the groups
B and C, at 4 h post STM14028-infection, without significant
differences within groups at 24 and 48 h post infection.
IL-1 beta blood level was higher in group A than in groups
B and C at 4 h post STM14028-infection. At 24 h post infection
we detected a reduction of the IL-1 beta blood concentration in
group A with a concomitant slightly increased level in group B.
Finally, the IL-1 beta level completely reversed its trend in groups
A and B at 48 h post infection, with higher concentration of IL1-b
in group B compared to group A (Figure 4).
These results confirm the induction of a pro-inflammatory
status mediated by LPS immediately after its administration.
Noteworthy, in group B the level of pro-inflammatory cytokines
required 48 h after infection to reach a concentration similar to
that measured in group A.
Piglets of the three groups were euthanized 48 h after the
treatments, and STM14028 infection was assessed in different
organs and tissues in order to evaluate the capability of colonizing
either locally in the gut milieu, or systemically. As depicted in
Figure 5, piglets treated with LPS and infected with STM14028
showed a significant increase in colonization of tonsils, cecum,
and spleen, whereas in mesenteric lymph nodes, colon, ileum
and liver no significant difference in STM14028 colonization was
observed (Figure 5).
On the whole, these findings provide substantial evidence
that LPS is able to induce an inflammatory response, which
favors STM14028 survival and colonization in the intestinal and
systemic compartments.
Discussion
Intestinal inflammation, induced by both chemical treatments
and infectious agents, is known to be associated with a profound
dysbiosis of the colonic microbial community structure
(Lupp et al., 2007). Many pathogens use inflammation and
the accompanying dysbiosis for their advantage in order to
overcome colonization resistance (Stecher et al., 2007). In this
context, several studies based on the use of the streptomycin-
treated mouse colitis model, which is characterized by absence
of resident microbiota (Ahmer and Gunn, 2011), highlighted the
emerging concept that inflammation of the mucosal epithelium
plays a role in environmental fitness of S. Typhimurium. It
has been shown, indeed, that unlike avirulent strains, wild-
type S. Typhimurium is capable of out-competing commensal
microbiota in re-colonization experiments after treatment with
antibiotics. Furthermore, S. Typhimurium exploits inflammation
to promote its own colonization, out-competing the resident
microbiota (Stecher et al., 2007). This model however, despite
the important contribution to the study of the pathogens-
microbiota interaction in an inflammatory environment,
presents several limitations. In particular, the inability of the
Salmonella mouse model to reproduce gastroenteritis and,
even more importantly, the elimination of the competing
flora represent crucial differences with respect to natural
Salmonella infection in humans. In this work, an experimental
model was used based on piglets infected with a wild type
strain of S. Typhimurium, STM14028, representing an ideal
animal model potentially capable to overcome the intrinsic
limitations of the current streptomycin-treated mouse colitis
model.
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FIGURE 2 | STM14028 colonization of mono-macrophages and IPEC-J2 cells at 3 and 24h post infection (A–D). STM14028 colonization increases with
LPS pre-treatment and is reduced by RS-LPS antagonist to the values of LPS-untreated cells (*P ≤ 0.1; **P ≤ 0.01, One-Way Anova Turkey’s multiple comparisons
test, data from one representative experiment out of three with similar results).
FIGURE 3 | LPS-treatment of piglets induces a rise in body temperature
4h after infection with STM14028. The body temperature was measured at
different time points on three different groups of piglets: treated with LPS and
infected with STM14028 (group A); only STM14028 infected (group B); naïve
control group (group C). At 4 h post infection, group A showed a significant rise
in body temperature compared to the B and C groups. Data refer to one out of
two separate experiments performed with comparable results. The differences
between groups were statistically significant (****P ≤ 0.0001; *P ≤ 0.1;
**P ≤ 0.01 multiple comparisons-Fisher’s Least Significant Difference test).
It was initially observed that, after oral infection with
STM14028, the immune response is rapidly activated,
involving the innate compartment with a marked increase
of polymorphonuclear and mono-macrophage populations
in ileo-cecal lymph nodes (Figure 1). This confirms the
involvement of the principal populations engaged in the
response to Salmonella infection, already known to be relevant
for the response to the LPS stimulation. Moreover, these
results extend those of recent studies about the increased
expression of pro-inflammatory cytokines (Knetter et al.,
2015) and raised lymphocytic infiltration of the gut mucosa
after S. Typhimurium oral infection of piglets (Gradassi et al.,
2013).
It was investigated whether the induction of inflammation
by LPS pre-treatment of mono-macrophages and porcine
intestinal epithelial IPEC-J2 cells makes these cells more
susceptible to STM14028 infection. The results indicate that
these cells, primed with LPS, were more prone to the
colonization by STM14028 when compared to the LPS-
untreated control cells. Otherwise, the use of the RS-LPS
antagonist, binding the TLR-4/MD-2 complex, inhibits the
LPS stimulation. This significantly reduced the STM14028
intracellular colonization down to the values of LPS-untreated
cells (Figure 2).
The higher colonization of STM14028 in LPS-treated cells
could be considered unexpected due to the effect of LPS
stimulus. It can however be hypothesized that our results are
the consequence of high capability of bacterial up-take. It
has been well-established, in fact, that for many facultative
intracellular pathogens, as well for Salmonella, the key to
successful infection lies in the interaction between bacteria and
host macrophages. Salmonella is able to mount specific strategies
to escape killing and survive within phagocytes (Fields et al.,
1986; Groisman and Saier, 1990; Gulig et al., 1998; Ruby et al.,
2012).Moreover, recent reports have revealed fascinating insights
to explain how Salmonella exploits host response. In particular,
the internalization of Salmonella in macrophages via TLR, able
to bind Salmonella LPS, is a crucial factor to favor Salmonella
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FIGURE 4 | LPS-treated piglets show an increased inflammation 4h
post STM14028 infection. IL-1beta and TNF-alpha production was
measured at different time points on blood samples from three different groups
of piglets: treated with LPS and infected with STM14028 (group A); only
STM14028 infected (group B); naïve control group (group C). At 4 h post
infection, group A showed a significant increase in production of both
cytokines compared to the B and C groups. The differences between the
groups were statistically significant (*P ≤ 0.1; **P ≤ 0.01, multiple
comparisons-Fisher’s Least Significant Difference test).
virulence in that it facilitates the acidification of the phagosome,
which in turn provides a protective niche for Salmonella (Arpaia
et al., 2011). In addition, in mouse models, it has been observed
that LPS present on live Salmonella provides an essential signal,
via functional TLR-4, for macrophages to produce NO and TNF-
α (Royle et al., 2003). This may be exploited by Salmonella
to modify macrophage functions and promote growth and/or
dissemination throughout the host.
Finally, the main effort was to assess whether the
inflammation induced LPS-treated piglets was able to influence
the colonization of STM14028. Piglets treated with LPS and
infected with STM14028 showed a significant increase in body
temperature (Figure 3) and the production of IL-1beta and TNF-
alpha in the blood (Figure 4) at 4 h post infection. These results
indicate that the onset of the LPS-mediated acute inflammation
leads to cytokines production and body temperature rise, already
at 4 h post infection, promoting significant increase of tonsils,
cecum, and spleen STM14028-colonization, compared to the
control group (Figure 5).
These results are in line with studies showing that the
parenteral administration of dead Gram-negative bacteria
or lipopolysaccharide exacerbated the growth of virulent
S. enterica in mice (Hormaeche, 1990). It is also possible
to envisage that the increased advantage of Salmonella in
FIGURE 5 | LPS treatment raises STM14028 colonization of tonsils,
cecum, and spleen of piglets. Recovery of STM14028 from different organs
at 48 h post infection of piglets treated with LPS and infected with STM14028
(LPS+STM group) or only infected with STM14028 (STM group).
LPS-treatment increases the colonization of tonsils, cecum, and spleen but
does not influence the colonization of mesenteric lymph nodes, colon, ileum,
and liver of piglets after STM14028 infection. Data refer to one out of two
separate experiments performed with comparable results. The differences
between the groups were statistically significant (*P ≤ 0.01, Mann–Whitney
unpaired t-test).
inflamed systemic environment can also be justified by
mechanisms other than a compromised barrier integrity or
dysbiosis. Moreover, Foster et al. demonstrated that the
intravenous administration of an attenuated Salmonella strain
can exacerbate the growth of virulent strains, which involves
IL-10 production and requires TLR-4, and its signaling
pathways involving the adaptor molecules, the TIR-domain-
containing adapter-inducing interferon-β (TRIF), and the
Myeloid differentiation primary response gene 88 (MyD88)
(Foster et al., 2008). A dysregulated type I IFN response in tissues
can affect fundamental regulatory circuits of innate immunity in
macrophages, which turns IL-10 into a potent pro-inflammatory
cytokine (Sharif et al., 2004). In addition, IL-10 and IFN-γ
associated responses may cause a gain of pro-inflammatory
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activity, as shown in human models of endotoxemia (Lauw et al.,
2000).
On the whole, these results, using piglets as model,
demonstrate for the first time that in acute enteric salmonellosis,
S. Typhimurium exploits the inflamed milieu to its own
advantage.
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